Microglia in neurodegenerative diseases

Y Xu, MZ Jin, ZY Yang, WL Jin - Neural Regeneration Research, 2021 - journals.lww.com
A major feature of neurodegeneration is disruption of central nervous system homeostasis,
during which microglia play diverse roles. In the central nervous system, microglia serve as …

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral …

V Sanchez-Guajardo, CJ Barnum, MG Tansey… - ASN …, 2013 - journals.sagepub.com
The role of neuroinflammation and the adaptive immune system in PD (Parkinson's disease)
has been the subject of intense investigation in recent years, both in animal models of …

Serpina3n: potential drug and challenges, mini review

MS Aslam, L Yuan - Journal of drug targeting, 2020 - Taylor & Francis
Serpina3n is a secretory serine protease inhibitor belonging to clade “a” exhibiting unique
structural and physiological characteristics, playing significant roles ranging from …

Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo

Y Haile, K Carmine-Simmen, C Olechowski… - Journal of …, 2015 - Springer
Background Multiple sclerosis (MS) is an autoimmune inflammatory and neurodegenerative
disease of the central nervous system (CNS). It is widely accepted that inflammatory cells …

Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics

GG Kovacs, G Botond, H Budka - Acta neuropathologica, 2010 - Springer
Neuropathological diagnosis of neurodegenerative dementias evolved by adapting the
results of neuroanatomy, biochemistry, and cellular and molecular biology. Milestone …

Urinary tract infections trigger synucleinopathy via the innate immune response

W Peelaerts, G Mercado, S George, M Villumsen… - Acta …, 2023 - Springer
Symptoms in the urogenital organs are common in multiple system atrophy (MSA), also in
the years preceding the MSA diagnosis. It is unknown how MSA is triggered and these …

Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis

LV Kalia, A Asis, N Arbour, A Bar-Or, R Bove… - Nature Reviews …, 2024 - nature.com
The development of disease-modifying therapies (DMTs) for neurological disorders is an
important goal in modern neurology, and the associated challenges are similar in many …

Imaging mechanisms of disease progression in multiple sclerosis: beyond brain atrophy

F Bagnato, SA Gauthier, C Laule… - Journal of …, 2020 - Wiley Online Library
Clinicians involved with different aspects of the care of persons with multiple sclerosis (MS)
and scientists with expertise on clinical and imaging techniques convened in Dallas, TX …

Pramipexole, a dopamine D2/D3 receptor-preferring agonist, prevents experimental autoimmune encephalomyelitis development in mice

V Lieberknecht, SC Junqueira, MP Cunha… - Molecular …, 2017 - Springer
Experimental autoimmune encephalomyelitis (EAE) is the most used animal model of
multiple sclerosis (MS) for the development of new therapies. Dopamine receptors can …

Predictive value of α-synuclein expression in peripheral blood of multiple sclerosis patients: A two-dimensional assessment of a selected biomarker

R Razia, F Majeed, R Amin, S Mukhtar, K Mahmood… - PLoS …, 2023 - journals.plos.org
Introduction Our study aimed to evaluate whether assessing α-synuclein expression levels
in blood samples could provide a reliable and straightforward alternative to existing …